Tenofovir Disoproxil

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9356 publications

Very late entecavir resistance after more than 10 years of therapy in a treatment-naïve patient with chronic hepatitis B genotype D3.

Very late entecavir resistance after more than 10 years of therapy in a treatment-naïve patient with chronic hepatitis B genotype D3.

Journal: Revista espanola de enfermedades digestivas

Published: June 18, 2026

Hepatitis B in pregnancy and breastfeeding: current approaches to prophylaxis and treatment.

Hepatitis B in pregnancy and breastfeeding: current approaches to prophylaxis and treatment.

Journal: Expert review of anti-infective therapy

Published: June 16, 2026

Comparing clinical and cytokine profiling of genital inflammation as predictors of HIV acquisition in women.

Comparing clinical and cytokine profiling of genital inflammation as predictors of HIV acquisition in women.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: June 12, 2026

Unraveling the Mechanism of HIV-1 Hypersusceptibility to Tenofovir Imparted by Islatravir Resistance Mutations.

Unraveling the Mechanism of HIV-1 Hypersusceptibility to Tenofovir Imparted by Islatravir Resistance Mutations.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

Integrating oral pre-exposure prophylaxis delivery in primary care family planning clinics: a pragmatic, stepped-wedge, cluster-randomised trial.

Integrating oral pre-exposure prophylaxis delivery in primary care family planning clinics: a pragmatic, stepped-wedge, cluster-randomised trial.

Journal: The Lancet. Primary care

Published: June 03, 2026

Letter: Reconsidering Tenofovir Disoproxil Fumarate Use in Light of Emerging Safety Evidence-Authors' Reply.

Letter: Reconsidering Tenofovir Disoproxil Fumarate Use in Light of Emerging Safety Evidence-Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: June 02, 2026

Updating "A nationally representative dataset of 1549 Americans aged 18 to 94 on interest in, experience with, and barriers to cogeneration, defined as working with older and younger people for social good" with data on religious identity and service attendance.

Updating "A nationally representative dataset of 1549 Americans aged 18 to 94 on interest in, experience with, and barriers to cogeneration, defined as working with older and younger people for social good" with data on religious identity and service attendance.

Journal: Data in brief

Published: June 01, 2026

Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysis.

Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysis.

Journal: Journal of comparative effectiveness research

Published: May 28, 2026

Effects of RNA Polymerase Inhibitors on Nucleotidylylation of Human Norovirus VPg.

Effects of RNA Polymerase Inhibitors on Nucleotidylylation of Human Norovirus VPg.

Journal: Antiviral research

Published: May 26, 2026

Acceptability and perspectives on clinic-based urine tenofovir testing for antiretroviral therapy adherence monitoring: qualitative findings from a randomized controlled trial in South Africa.

Acceptability and perspectives on clinic-based urine tenofovir testing for antiretroviral therapy adherence monitoring: qualitative findings from a randomized controlled trial in South Africa.

Journal: AIDS care

Published: May 26, 2026

Metallic 1T NaxMoS2 as Sulfur Host for Room Temperature Na-S Batteries.

Metallic 1T NaxMoS2 as Sulfur Host for Room Temperature Na-S Batteries.

Journal: ACS nano

Published: May 20, 2026

Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline-A Step Towards Functional Cure or a Marginal Margin? Authors' Reply.

Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline-A Step Towards Functional Cure or a Marginal Margin? Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: May 15, 2026

Showing 1-12 of 9,356

Last Updated: 06/30/2026